Riskpilot← Back to searchSign inGet full accessCuraz Zaras hälsofokus AB
ABActiveOrg 5593185456Rehnsgatan 24Day spa, sauna and steam bath activities · NACE 9623Est. 20212 employees
Revenue 2024
SEK 1,5M
+18% vs 2023
EBITDA margin
11.4%
+215% vs 2023
Equity ratio
5.0%
Financial strength
Net profit 2024
SEK 65K
+885% vs 2023
| Revenue | SEK 1,5M | +18% |
| EBITDA | SEK 175K | +215% |
| Net profit | SEK 65K | +885% |
| Total assets | SEK 1,4M | +14% |
| Equity | SEK 68K | +202% |
| Employees | 2 | — |
Legal name
Curaz Zaras hälsofokus AB
Org number
5593185456
Legal form
Aktiebolag
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
20 maj 2021
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Stressrelaterad behandling och rådgivning, främst LPG-massage och samtalsterapi. Föreläsningar om ledarskap, deltagarskap och samhällsfrågor.
Address
Rehnsgatan 24
Email
info@zarashalsofokus.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 250 | 1 040 | 1 300 | 1 532 |
| Staff expenses | — | −671 | −962 | −1 041 |
| EBITDA | −68 | 4 | 56 | 175 |
| Depreciation & amort. | −9 | −16 | −25 | −69 |
| EBIT | −77 | −12 | 31 | 106 |
| Net financials | −1 | −10 | −24 | −35 |
| Profit before tax | −78 | −21 | 7 | 71 |
| Tax | −0 | — | — | −5 |
| Net profit | −78 | −21 | 7 | 65 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 879 | 1 037 | 1 198 | 1 363 |
| Equity | 699 | 663 | 22 | 68 |
| Long-term debt | 0 | — | 907 | 1 031 |
| Short-term debt | 180 | 374 | 269 | 265 |
| Total debt | 180 | 374 | 1 176 | 1 295 |
EBITDA margin
11.4%
This company
15.8%
Market median
-28% vs market
20212024
Equity ratio
5.0%
This company
38.2%
Market median
-87% vs market
20212024
Return on equity
96.5%
This company
18.4%
Market median
+424% vs market
20212024
Net profit margin
4.3%
This company
8.1%
Market median
-47% vs market
20212024
Asset turnover
1.12×
This company
1.12×
Market median
+0% vs market
20212024
Debt / equity
19.18×
This company
0.62×
Market median
-2994% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-05-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Chairman | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Curaz Zaras hälsofokus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Shima Ghorbani Balakafshe | Deputy Board Member | 0 companies |
| Zara Ansari Hamadani | Chairman | 0 companies |
| Max Masoud Ansari | Board of Directors | 0 companies |
| Lars Christer Bryntesson | Chairman | 0 companies |